Cargando…

The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer

BACKGROUND: Telomerase reverse transcriptase (TERT) promoter mutations have been described in different pathological types of thyroid cancers (TC). After many types of research focusing on the mutations rate in malignant tumors, the main role of TERT promoter mutations has been changed to the preope...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Anqi, Xu, Jianhao, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086515/
https://www.ncbi.nlm.nih.gov/pubmed/30024548
http://dx.doi.org/10.1097/MD.0000000000011548
_version_ 1783346529970421760
author Jin, Anqi
Xu, Jianhao
Wang, Yan
author_facet Jin, Anqi
Xu, Jianhao
Wang, Yan
author_sort Jin, Anqi
collection PubMed
description BACKGROUND: Telomerase reverse transcriptase (TERT) promoter mutations have been described in different pathological types of thyroid cancers (TC). After many types of research focusing on the mutations rate in malignant tumors, the main role of TERT promoter mutations has been changed to the preoperative diagnosis and prognosis of TC, according to their high prevalence in aggressive TC. METHODS: We searched Pubmed, Web of Science, Scopus, and VHL and reviewed the most common 2 mutations C288T and C250T in different types of TC, the association between them and some specific clinicopathological features, and their significance in preoperative diagnosis and prognosis of TC. we chose 38 studies into our qualitative research. We also chose 22 studies to do a meta-analysis on this subject. RESULTS: The overall rate of these mutations in different types of TC was 10.0%, with 86.1% C228T mutation, 12% C250T mutation, and 2.1% other type mutations. The rate increases significantly as the TC become more aggressive, and reaches 56.8% in anaplastic thyroid cancer (ATC). Statistically meaningful association is found between TERT promoter mutations and older age, larger tumor size, extrathyroidal extension, lymph node metastasis, distance metastasis, advanced TNM stage, recurrence, and BRAF V600E mutation. Some studies concentrating on DNA sequencing based on fine needle aspiration biopsy (FNAB) also proved their significance in preoperative stage, with 7% to 16.5% sensitivity. CONCLUSIONS: TERT promoter mutations were likely to occur in BRAF V600E positive TC. Patients with these 2 combined mutations were more likely to have a poor prognosis and outcome. TERT promoter mutations is an essential part of the ThySeq gene panel. The mechanism of how they influence the appearance and development of TC has not been expounded. The next study direction may be the mechanism exploration and the further study to prove their significance in preoperative diagnosis.
format Online
Article
Text
id pubmed-6086515
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-60865152018-08-17 The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer Jin, Anqi Xu, Jianhao Wang, Yan Medicine (Baltimore) Research Article BACKGROUND: Telomerase reverse transcriptase (TERT) promoter mutations have been described in different pathological types of thyroid cancers (TC). After many types of research focusing on the mutations rate in malignant tumors, the main role of TERT promoter mutations has been changed to the preoperative diagnosis and prognosis of TC, according to their high prevalence in aggressive TC. METHODS: We searched Pubmed, Web of Science, Scopus, and VHL and reviewed the most common 2 mutations C288T and C250T in different types of TC, the association between them and some specific clinicopathological features, and their significance in preoperative diagnosis and prognosis of TC. we chose 38 studies into our qualitative research. We also chose 22 studies to do a meta-analysis on this subject. RESULTS: The overall rate of these mutations in different types of TC was 10.0%, with 86.1% C228T mutation, 12% C250T mutation, and 2.1% other type mutations. The rate increases significantly as the TC become more aggressive, and reaches 56.8% in anaplastic thyroid cancer (ATC). Statistically meaningful association is found between TERT promoter mutations and older age, larger tumor size, extrathyroidal extension, lymph node metastasis, distance metastasis, advanced TNM stage, recurrence, and BRAF V600E mutation. Some studies concentrating on DNA sequencing based on fine needle aspiration biopsy (FNAB) also proved their significance in preoperative stage, with 7% to 16.5% sensitivity. CONCLUSIONS: TERT promoter mutations were likely to occur in BRAF V600E positive TC. Patients with these 2 combined mutations were more likely to have a poor prognosis and outcome. TERT promoter mutations is an essential part of the ThySeq gene panel. The mechanism of how they influence the appearance and development of TC has not been expounded. The next study direction may be the mechanism exploration and the further study to prove their significance in preoperative diagnosis. Wolters Kluwer Health 2018-07-20 /pmc/articles/PMC6086515/ /pubmed/30024548 http://dx.doi.org/10.1097/MD.0000000000011548 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Research Article
Jin, Anqi
Xu, Jianhao
Wang, Yan
The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer
title The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer
title_full The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer
title_fullStr The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer
title_full_unstemmed The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer
title_short The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer
title_sort role of tert promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086515/
https://www.ncbi.nlm.nih.gov/pubmed/30024548
http://dx.doi.org/10.1097/MD.0000000000011548
work_keys_str_mv AT jinanqi theroleoftertpromotermutationsinpostoperativeandpreoperativediagnosisandprognosisinthyroidcancer
AT xujianhao theroleoftertpromotermutationsinpostoperativeandpreoperativediagnosisandprognosisinthyroidcancer
AT wangyan theroleoftertpromotermutationsinpostoperativeandpreoperativediagnosisandprognosisinthyroidcancer
AT jinanqi roleoftertpromotermutationsinpostoperativeandpreoperativediagnosisandprognosisinthyroidcancer
AT xujianhao roleoftertpromotermutationsinpostoperativeandpreoperativediagnosisandprognosisinthyroidcancer
AT wangyan roleoftertpromotermutationsinpostoperativeandpreoperativediagnosisandprognosisinthyroidcancer